Despite the loss of the company’s COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of Dupixent and Eylea.

Relevate Health solidified the healthcare marketing agency’s position as a market leader in healthcare professional (HCP) omnichannel engagement with the acquisition of Dallas-based ConneXion360. With this acquisition, Relevate Health now provides its omnichannel solutions and agency services to more than 185 brands from 90 pharmaceutical, biotech, and medical device manufacturers, as well as 24 hospital systems.

Pfizer boosts respiratory drug portfolio with ReViral purchase April 7, 2022 By Bhanvi Satija April 7 (Reuters) – Pfizer Inc (PFE.N) said on Thursday it would buy privately-held ReViral Ltd […]

Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced it acquired Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm. 

Pfizer building sign logo

The share price of Arena Pharmaceuticals nearly doubled in premarket trading after pharma giant Pfizer announced the acquisition of the company and its diverse portfolio of developmental and clinical assets – including a late-stage ulcerative colitis treatment – in an all-cash deal valued at $6.7 billion.

Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced the acquisition of MedThink, a North Carolina–based company that empowers healthcare providers through medical communications.

Pfizer is buying Toronto and Cambridge, Massachusetts-based Trillium Therapeutics in a deal worth $2.26 billion. Trillium focuses on developing a new set of checkpoint inhibitors to treat cancer.

The Securities and Exchange Commission (SEC) is charging Matthew Panuwat – a former business development executive at Medivation – with insider trading, according to a complaint filed in court stemming from Pfizer’s acquisition of Medivation in 2016.

Philip Morris continues to expand the tobacco giant’s ‘Beyond Nicotine’ strategy by acquiring Michigan-based OtiTopic, a company developing inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction.

Sanofi agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as the French pharmaceuticals firm bets on next-generation mRNA vaccine technology beyond the Covid-19 pandemic, confirming a Reuters exclusive report.